{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:44:05Z","timestamp":1787798645331,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T00:00:00Z","timestamp":1540598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"HelseNord","award":["HNF 1387-17"],"award-info":[{"award-number":["HNF 1387-17"]}]},{"name":"Wellcome Trust Senior Fellowship in Clinical Science","award":["206316\/Z\/17\/Z"],"award-info":[{"award-number":["206316\/Z\/17\/Z"]}]}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ijid.2018.10.019","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T21:52:23Z","timestamp":1541022743000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Patterns of detectable viraemia among children and adults with HIV infection taking antiretroviral therapy in Zimbabwe"],"prefix":"10.1016","volume":"78","author":[{"given":"Evgeniya","family":"Sovershaeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinei","family":"Shamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wilsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsitsi","family":"Bandason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond","family":"Fl\u00e6gstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Katzenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashida A.","family":"Ferrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Odland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2018.10.019_bib0005","series-title":"Global report 2013","author":"UNAIDS","year":"2013"},{"issue":"8","key":"10.1016\/j.ijid.2018.10.019_bib0010","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","author":"Antiretroviral Therapy Cohort C","year":"2017","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.ijid.2018.10.019_bib0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/QAD.0000000000000544","article-title":"Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients","volume":"29","author":"Antiretroviral Therapy Cohort C","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2018.10.019_bib0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2334-13-113","article-title":"Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria","volume":"13","author":"Anude","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2018.10.019_bib0025","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/cid\/ciw645","article-title":"Suboptimal viral suppression rates among HIV-infected children in low- and middle-income countries: a meta-analysis","volume":"63","author":"Boerma","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2018.10.019_bib0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.meegid.2016.08.031","article-title":"HIV-1 drug resistance and resistance testing","volume":"46","author":"Clutter","year":"2016","journal-title":"Infect Genet Evol"},{"issue":"9","key":"10.1016\/j.ijid.2018.10.019_bib0035","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission","volume":"375","author":"Cohen","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ijid.2018.10.019_bib0040","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/QAD.0b013e3282f88d02","article-title":"Response to combination antiretroviral therapy: variation by age","volume":"22","author":"Collaboration of Observational HIVERESG","year":"2008","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ijid.2018.10.019_bib0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3851\/IMP3041","article-title":"Improved survival in HIV treatment programmes in Asia","volume":"21","author":"De La Mata","year":"2016","journal-title":"Antivir Ther"},{"issue":"11","key":"10.1016\/j.ijid.2018.10.019_bib0050","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/00002030-200207260-00009","article-title":"The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to <400 copies\/ml","volume":"16","author":"Easterbrook","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2018.10.019_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12981-016-0100-4","article-title":"Factors associated with HIV viral load \u201cblips\u201d and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case-control study","volume":"13","author":"Farmer","year":"2016","journal-title":"AIDS Res Ther"},{"issue":"11","key":"10.1016\/j.ijid.2018.10.019_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187566","article-title":"Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaounde-Cameroon","volume":"12","author":"Fokam","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijid.2018.10.019_bib0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/QAI.0b013e3182487a20","article-title":"The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: are we ready to infer poor adherence?","volume":"60","author":"Fung","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.ijid.2018.10.019_bib0070","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cid\/ciu019","article-title":"Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals","volume":"58","author":"Gonzalez-Serna","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2018.10.019_bib0075","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/infdis\/jis104","article-title":"Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis","volume":"205","author":"Grennan","year":"2012","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2018.10.019_bib0080","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/S2352-3018(15)00087-9","article-title":"Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis","volume":"2","author":"Haas","year":"2015","journal-title":"Lancet HIV"},{"issue":"2","key":"10.1016\/j.ijid.2018.10.019_bib0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.286.2.171","article-title":"Prevalence and predictive value of intermittent viremia with combination hiv therapy","volume":"286","author":"Havlir","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijid.2018.10.019_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116144","article-title":"Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland","volume":"10","author":"Jobanputra","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijid.2018.10.019_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086122","article-title":"The significance of HIV \u2018blips\u2019 in resource-limited settings: is it the same? analysis of the treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD)","volume":"9","author":"Kanapathipillai","year":"2014","journal-title":"PLoS One"},{"issue":"2 Suppl. 1","key":"10.1016\/j.ijid.2018.10.019_bib0100","doi-asserted-by":"crossref","first-page":"19393","DOI":"10.7448\/IAS.18.2.19393","article-title":"Review: an urgent need for research on factors impacting adherence to and retention in care among HIV-positive youth and adolescents from key populations","volume":"18","author":"Lall","year":"2015","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"10.1016\/j.ijid.2018.10.019_bib0105","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/cid\/cit529","article-title":"Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation","volume":"57","author":"Laprise","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2018.10.019_bib0110","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/135965350701200603","article-title":"Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean?","volume":"12","author":"Lee","year":"2007","journal-title":"Antivir Ther"},{"issue":"2","key":"10.1016\/j.ijid.2018.10.019_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw089","article-title":"A single quantifiable viral load is predictive of virological failure in human immunodeficiency virus (HIV)-infected patients on combination antiretroviral therapy: the Austrian HIV cohort study","volume":"3","author":"Leierer","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2018.10.019_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144057","article-title":"Clinical, virologic, immunologic outcomes and emerging HIV. Drug resistance patterns in children and adolescents in public ART care in Zimbabwe","volume":"10","author":"Makadzange","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ijid.2018.10.019_bib0125","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.aids.0000174453.55627.de","article-title":"HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen","volume":"19","author":"Martinez","year":"2005","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.ijid.2018.10.019_bib0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00006454-199612000-00006","article-title":"Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus","volume":"15","author":"McIntosh","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.ijid.2018.10.019_bib0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/aid.2015.0296","article-title":"Younger age predicts failure to achieve viral suppression and virologic rebound among HIV-1-infected persons in serodiscordant partnerships","volume":"32","author":"Mujugira","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"12","key":"10.1016\/j.ijid.2018.10.019_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167465","article-title":"Rates and predictors of non-adherence to antiretroviral therapy among HIV-positive individuals in Kenya: results from the second Kenya AIDS indicator survey, 2012","volume":"11","author":"Mukui","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2018.10.019_bib0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2334-14-28","article-title":"Virological efficacy and immunological recovery among Ethiopian HIV-1 infected adults and children","volume":"14","author":"Mulu","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2018.10.019_bib0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAI.0b013e318199072e","article-title":"Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa","volume":"51","author":"Nachega","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.ijid.2018.10.019_bib0155","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.293.7.817","article-title":"Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART","volume":"293","author":"Nettles","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2018.10.019_bib0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2334-12-100","article-title":"HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability","volume":"12","author":"Ruelle","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2018.10.019_bib0165","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1128\/AAC.00076-14","article-title":"Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients","volume":"58","author":"Ryscavage","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2018.10.019_bib0170","doi-asserted-by":"crossref","first-page":"20683","DOI":"10.7448\/IAS.19.1.20683","article-title":"High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo","volume":"19","author":"Salou","year":"2016","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"10.1016\/j.ijid.2018.10.019_bib0175","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/hiv.12103","article-title":"The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrations","volume":"15","author":"Samuel","year":"2014","journal-title":"HIV Med"},{"issue":"15","key":"10.1016\/j.ijid.2018.10.019_bib0180","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/00002030-200210180-00008","article-title":"Prevalence and clinical correlates of HIV viremia (\u2018blips\u2019) in patients with previous suppression below the limits of quantification","volume":"16","author":"Sklar","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2018.10.019_bib0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12879-016-1628-6","article-title":"Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels","volume":"16","author":"Sorstedt","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2018.10.019_bib0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JCM.02461-13","article-title":"Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration","volume":"52","author":"Swenson","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.ijid.2018.10.019_bib0195","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/QAD.0000000000000203","article-title":"HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure","volume":"28","author":"Swenson","year":"2014","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.ijid.2018.10.019_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002432","article-title":"Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: observational analyses within the randomised ARROW trial","volume":"14","author":"Szubert","year":"2017","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ijid.2018.10.019_bib0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/pch\/13.1.19","article-title":"Adherence to treatment in adolescents","volume":"13","author":"Taddeo","year":"2008","journal-title":"Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.ijid.2018.10.019_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QAI.0b013e3182895af4","article-title":"CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy","volume":"63","author":"Taiwo","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2018.10.019_bib0215","series-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.ijid.2018.10.019_bib0220","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12879-015-1120-8","article-title":"Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study","volume":"15","author":"Young","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2018.10.019_bib0225","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/hiv.12134","article-title":"Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals","volume":"15","author":"Zoufaly","year":"2014","journal-title":"HIV Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971218345673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971218345673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:25:09Z","timestamp":1662337509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971218345673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"alternative-id":["S1201971218345673"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2018.10.019","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of detectable viraemia among children and adults with HIV infection taking antiretroviral therapy in Zimbabwe","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2018.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}